The latest update is out from C4 Therapeutics ( (CCCC) ).
Hoerter Brings Over Three Decades of Oncology Commercialization and Leadership ExperienceAppointment Underscores Continued ...
Fintel reports that on November 18, 2024, Stephens & Co. initiated coverage of C4 Therapeutics (NasdaqGS:CCCC) with a ...